Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
2,657,174
-
Share change
-
-5,740
-
Total reported value
-
$4,756,000
-
Price per share
-
$1.79
-
Number of holders
-
10
-
Value change
-
-$8,606
-
Number of buys
-
4
-
Number of sells
-
3
Institutional Holders of SUMMIT THERAPEUTICS INC COM - Stock (SMMT) as of Q3 2019
As of 30 Sep 2019 SUMMIT THERAPEUTICS INC COM - Stock (SMMT) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,657,174 shares of stock of the company.
Largest 10 holders included LANSDOWNE PARTNERS (UK) LLP, Polar Capital LLP, MORGAN STANLEY, Bank of New York Mellon Corp, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, UBS Group AG, and Larson Financial Group LLC.
This table shows 10 institutional shareholders of the security as of 30 Sep 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.